PRODUCT MONOGRAPH - Sanofi
PLAVIX Product Monograph Page 1 of 55 . PRODUCT MONOGRAPH . PrPLAVIX®. Clopidogrel Tablets, Manufacturer’s Standard . 75 …
Download PRODUCT MONOGRAPH - Sanofi
Information
Domain:
Source:
Link to this page:
Documents from same domain
Lantus SOLOSTAR - Sanofi
products.sanofi.caPage 1 LANTUS ® SOLOSTAR ® Instruction Leaflet . SoloSTAR ® is a prefilled pen for the injection of insulin. Your health professional has decided that SoloSTAR is appropriate for you, based on your ability to handle SoloSTAR.
Kayexalate (sodium polystyrene sulfonate) - Sanofi
products.sanofi.caKAYEXALATE (sodium polystyrene sulfonate) is a cream or light brown fine powder of sodium polystyrene sulfonate. KAYEXALATE is a cation-exchange resin prepared in the
![Thymoglobulin (anti-thymocyte globulin [rabbit]) - …](/cache/preview/a/b/2/e/e/b/8/2/thumb-ab2eeb82468088f352549e7d8dab340f.jpg)
Thymoglobulin (anti-thymocyte globulin [rabbit]) - …
products.sanofi.caLive vaccines should not be administered to patients about to receive, receiving, or after treatment with Thymoglobulin. Concomitant administration of Thymoglobulin with live virus
PRODUCT MONOGRAPH - Sanofi
products.sanofi.caCLOLAR® (clofarabine for injection) Page 1 of 41. PRODUCT MONOGRAPH . PrCLOLAR®. Clofarabine for injection . 1 mg/mL (20 mg/20 mL) Antineoplastic Agent . sanofi-aventis Canada Inc. 2905 Place Louis-R.-Renaud
Myochrysine (sodium aurothiolamate) - Sanofi
products.sanofi.ca3 It is usually used for treating patients who show evidence of continued or additional disease activity despite conservative drug therapy, e.g. with salicylates or …
PRODUCT MONOGRAPH INCLUDING PATIENT …
products.sanofi.caADLYXINE - Product Monograph Page 1 of 79. PRODUCT MONOGRAPH . INCLUDING PATIENT MEDICATION INFORMATION . Pr ADLYXINE™ . lixisenatide injection . 0.05 mg per mL (10 μg/dose)
PRODUCT MONOGRAPH INCLUDING PATIENT …
products.sanofi.caPage 1 of 64. PRODUCT MONOGRAPH. INCLUDING PATIENT MEDICATION INFORMATION . PrPRALUENT®. alirocumab . solution for subcutaneous injection . 75 mg/mL and 150 mg/mL
Renvela (sevelamer carbonate) - Sanofi
products.sanofi.caRenvela (sevelamer carbonate) Product Monograph Page 1 of 21. PRODUCT MONOGRAPH . PrRENVELA®. sevelamer carbonate tablets . 800 mg . Phosphate Binder . ATC code: VO3A EO2
PRODUCT MONOGRAPH LANTUS - Sanofi
products.sanofi.caPage 1 of 62 . PRODUCT MONOGRAPH . LANTUS®. Insulin glargine injection (rDNA origin) Solution for injection 100 U/mL . ATC code: A10AE04 . Antidiabetic Agent
Sculptra (poly-L-lactic acid) - Sanofi
products.sanofi.caApplication number: 200845 Page 1 of 7 Date of revision: September 17, 2012 s-a Version 2.3 dated September 19, 2012 Instruction Leaflet SCULPTRA® poly-L-lactic acid
Related documents
What is platelet-rich plasma (PRP)? How is PRP …
cnsa.comConcord Office-On-site MRI 100 Lake Concord Rd. NE Concord, NC 28025 704-792-2672 Huntersville Office 9735 Kincey Ave., Ste 300 Huntersville, NC 28078
Guidelines for Use of Clopidogrel (Plavix®)
oscarmanual.orgPage 2 of 5 3. Cardiovascular Disease -For patients with IHD, ischaemic cerebral infarction, TIA or peripheral artery disease who are unable to take aspirin due to contraindication, or known allergy (bronchospasm or rash). 4.
US-19233 ------------------------- DOSAGE AND ...
www.azpicentral.comHIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use BRILINTA safely and effectively. See full prescribing information for BRILINTA.
ANEXO I FICHA TÉCNICA O RESUMEN DE LAS …
www.ema.europa.eu2 1. NOMBRE DEL MEDICAMENTO Plavix 75 mg comprimidos recubiertos con película Plavix 300 mg comprimidos recubiertos con película 2. COMPOSICIÓN CUALITATIVA Y …
TriLyte Preparation Instructions - Colonoscopy
www.gastroenterologistpaloalto.comTriLyte Preparation Instructions You are scheduled to have a Colonoscopy.Dr. David Shields will perform this procedure on _____/_____ at _____AM/PM at the Palo Alto Endoscopy Center.
ANNEXE A : Modèle de formulaire de demande - …
www.huisarts.beI – Identification du bénéficiaire (nom, prénom, N° d’affiliation à l’O.A.): ..... ..... III – Identification du médecin traitant (nom, prénom, adresse ...